1 ECFMG Certified, USMLE (United States Medical Licensing Examination), M. B. Ch. B, University of Baghdad, Iraq.
2 M. B. Ch. B, University of Basrah, Iraq. American Boards of Family Medicine, Detroit Medical Center (DMC), Michigan, USA.
Received on 22 June 2024; revised on 28 July 2024; accepted on 31 July 2024
Upon reviewing the effects of many anti-hypertensive medications on patients, we noticed that some medications are working more efficiently in Middle Eastern communities while others are less efficient, so we decided to test the effects of lisinopril and valsartan in a single-blinded clinical trial on a Middle Eastern community sample.
We chose a random sample of 100 patients and followed them up with treatment for one month of each medication, and we found out that both ACE inhibitors and ARBs are effective in terms of lowering both systolic and diastolic blood pressures with a slightly better efficacy for lisinopril.
Anti-hypertensive medications; ACE inhibitors; ARBs; Lisinopril and valsartan; Medication efficacy; Middle Eastern community sample
Preview Article PDF
Karam Zakariya Hadi and Laith Matti Potrous. The efficacy difference between lisinopril and valsartan among Middle Eastern communities. World Journal of Biology Pharmacy and Health Sciences, 2024, 19(02), 189–190. Article DOI: https://doi.org/10.30574/wjbphs.2024.19.2.0476